Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Symbiox Inc. currently manages 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 2 distinct art units, which reflects the technical classification of the company's intellectual property. The involvement of 2 distinct examiners indicates that the portfolio is not concentrated under a single individual's review, providing a broader perspective on the prosecution of these applications.
The busiest examiner for the company is MARTIN, PAUL C, who is currently managing 1 pending office action. This specific action accounts for a portion of the 2 pending office actions currently active for the portfolio. Because the workload is split between 2 distinct examiners and 2 distinct art units, the prosecution strategy must account for different examiner styles and art unit norms. This distribution suggests that while the portfolio is small, it requires monitoring across multiple points of contact within the USPTO's Biotechnology & Pharmaceuticals sector.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MARTIN, PAUL C | 1 | 41.8% | +21.6% |
| TAYLOR, APRIL ALICIA | 1 | 78.8% | +8.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18273974 | PHOTOSYNTHETIC COMPOSITIONS AND METHODS OF PREPARING AND USING PHOTOSYNTHETIC COMPOSITIONS | MARTIN, PAUL C | 33d |
| 18033523 | ILLUMINATION DEVICES, SYSTEMS AND METHODS | TAYLOR, APRIL ALICIA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18273974 | PHOTOSYNTHETIC COMPOSITIONS AND METHODS OF PREPARING AND USING PHOTOSYNTHETIC COMPOSITIONS | MARTIN, PAUL C | 33d |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| 2876 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18273974 | PHOTOSYNTHETIC COMPOSITIONS AND METHODS OF PREPARING AND USING PHOTOSYNTHETIC COMPOSITIONS | MARTIN, PAUL C | 1653 | §103§112 | Final Rejection | 33d | Pending | Jul 24, 2023 |
| 18033523 | ILLUMINATION DEVICES, SYSTEMS AND METHODS | TAYLOR, APRIL ALICIA | 2876 | §102§103§112 | Non-Final OA | — | Pending | Apr 24, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial